Yongfei Li - Publications

Homogeneous Memristors with Tunable Decay Dynamics for Self-Adaptive Reservoir Computing.

Journal: ACS nano

Published: July 29, 2025

Construction of a novel disulfidptosis-associated lncRNAs signature for risk features and immunotherapy in breast cancer.

Journal: Translational cancer research

Published: November 27, 2024

m6A mRNA methylation initiated by METTL14 promotes STK11 translation and increases STK11 activity to induce anti-HER2 therapy resistance in breast cancer.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: September 10, 2024

Crossmodal sensory neurons based on high-performance flexible memristors for human-machine in-sensor computing system.

Journal: Nature communications

Published: March 05, 2024

Occult breast cancer presenting with pathological fracture: A case report.

Journal: Asian journal of surgery

Published: September 20, 2023

Diselenium-linked dimeric prodrug nanomedicine breaking the intracellular redox balance for triple-negative breast cancer targeted therapy.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: May 07, 2023

JWA suppresses proliferation in trastuzumab-resistant breast cancer by downregulating CDK12.

Journal: Cell death discovery

Published: April 28, 2021

Sanhuang Decoction Controls Tumor Microenvironment by Ameliorating Chronic Stress in Breast Cancer: A Report of Ninety Cases.

Journal: Frontiers in oncology

Published: March 08, 2021

San Huang Decoction Targets Aurora Kinase A to Inhibit Tumor Angiogenesis in Breast Cancer.

Journal: Integrative cancer therapies

Published: December 22, 2020

Dual pH/ROS-Responsive Nanoplatform with Deep Tumor Penetration and Self-Amplified Drug Release for Enhancing Tumor Chemotherapeutic Efficacy.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: April 04, 2020

Lapatinib in combination with capecitabine versus continued use of trastuzumab in breast cancer patients with trastuzumab-resistance: a retrospective study of a Chinese population.

Journal: BMC cancer

Published: October 20, 2019

Transferrin receptor-targeted redox/pH-sensitive podophyllotoxin prodrug micelles for multidrug-resistant breast cancer therapy.

Journal: Journal of materials chemistry. B

Published: September 10, 2019